Immunotherapy After Chemoradiotherapy for Sinonasal NUT Carcinoma
Author Information
Author(s): Geng Xiaotao, Chang Xiaolong, Wang Xiaoli, Li Shunjia, Han Guiyan, Song Zhiyu, Hao Furong, Li Jianwen
Primary Institution: Weifang People’s Hospital, Weifang, China
Hypothesis
Can consolidation immunotherapy improve outcomes for patients with sinonasal NUT carcinoma after chemoradiotherapy?
Conclusion
Consolidation immunotherapy with a PD-1 inhibitor after chemoradiotherapy showed promising efficacy in a patient with sinonasal NUT carcinoma.
Supporting Evidence
- The patient achieved a favorable outcome after treatment.
- She survived for 31 months without signs of recurrence or metastasis.
Takeaway
A woman with a rare type of cancer got special treatment after her initial therapy, and it helped her stay healthy for a long time.
Methodology
The patient underwent concurrent chemoradiotherapy followed by consolidation chemotherapy and immunotherapy with a PD-1 inhibitor.
Limitations
This is a single case report, limiting the generalizability of the findings.
Participant Demographics
The patient was a 44-year-old female from Shandong, China.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website